Literature DB >> 12607151

Detecting exaggeration and malingering with the trail making test.

Grant L Iverson1, Rael T Lange, Paul Green, Michael D Franzen.   

Abstract

The purpose of this study was to examine whether unusual performance on the Trail Making Test could be indicative of deliberate exaggeration. Participants were 571 patients seen as part of a hospital trauma service who had acute traumatic brain injuries, and 228 patients involved in head injury litigation. As expected, the hospital patients with more severe traumatic brain injuries performed more poorly than the patients with less severe brain injuries on Trails A and Trails B. Cutoff score tables were developed for the patients with acute traumatic brain injuries for the total sample and by injury severity groups. Scores falling at or below the 5th percentile were considered suspicious for possible exaggeration. The performances of the head injury litigants who exaggerated on at least one well-validated symptom validity test were compared to these cutoffs. Very high positive predictive values for individuals with very mild head injuries on Trails A and B were identified (i.e., both 100%); lower positive predictive values were obtained for individuals with more severe head injuries (55.6-60%). The negative predictive values were only moderate (range=66.4-78.2%), and the sensitivity was very low (range = 7.1-18.5%) for all groups. Scores that fall in the range of possible biased responding should be considered "red flags" for the clinician because they likely do not make biological or psychometric sense. However, the sensitivity of the test for deliberate exaggeration is very low, so clinicians who rely on this test in isolation to identify deliberately poor performance will fail to identify the vast majority of cases.

Entities:  

Mesh:

Year:  2002        PMID: 12607151     DOI: 10.1076/clin.16.3.398.13861

Source DB:  PubMed          Journal:  Clin Neuropsychol        ISSN: 1385-4046            Impact factor:   3.535


  12 in total

1.  Neural activation during response inhibition differentiates blast from mechanical causes of mild to moderate traumatic brain injury.

Authors:  Barbara L Fischer; Michael Parsons; Sally Durgerian; Christine Reece; Lyla Mourany; Mark J Lowe; Erik B Beall; Katherine A Koenig; Stephen E Jones; Mary R Newsome; Randall S Scheibel; Elisabeth A Wilde; Maya Troyanskaya; Tricia L Merkley; Mark Walker; Harvey S Levin; Stephen M Rao
Journal:  J Neurotrauma       Date:  2013-11-01       Impact factor: 5.269

2.  Educational attainment is not a good proxy for cognitive function in methamphetamine dependence.

Authors:  Andy C Dean; Gerhard Hellemann; Catherine A Sugar; Edythe D London
Journal:  Drug Alcohol Depend       Date:  2011-12-27       Impact factor: 4.492

3.  The impact of PTSD and mTBI on the relationship between subjective and objective cognitive deficits in combat-exposed veterans.

Authors:  Elsa K Mattson; Nathaniel W Nelson; Scott R Sponheim; Seth G Disner
Journal:  Neuropsychology       Date:  2019-06-13       Impact factor: 3.295

4.  Dementia-Related Neuropsychological Testing Considerations in Non-Hispanic White and Latino/Hispanic Populations.

Authors:  Shanna L Burke; Mitra Naseh; Miriam J Rodriguez; Aaron Burgess; David Loewenstein
Journal:  Psychol Neurosci       Date:  2019-03-11

Review 5.  Victoria Symptom Validity Test: A Systematic Review and Cross-Validation Study.

Authors:  Zachary J Resch; Troy A Webber; Matthew T Bernstein; Tasha Rhoads; Gabriel P Ovsiew; Jason R Soble
Journal:  Neuropsychol Rev       Date:  2021-01-12       Impact factor: 7.444

6.  Cognitive deficit in methamphetamine users relative to childhood academic performance: link to cortical thickness.

Authors:  Andy C Dean; Angelica M Morales; Gerhard Hellemann; Edythe D London
Journal:  Neuropsychopharmacology       Date:  2018-04-20       Impact factor: 7.853

7.  Predictors and Impact of Self-Reported Suboptimal Effort on Estimates of Prevalence of HIV-Associated Neurocognitive Disorders.

Authors:  Andrew J Levine; Eileen Martin; Ned Sacktor; Cynthia Munro; James Becker
Journal:  J Acquir Immune Defic Syndr       Date:  2017-06-01       Impact factor: 3.731

8.  Evidence for neuropsychological health disparities in Black Americans with HIV disease.

Authors:  Jennifer L Thompson; Ilex Beltran-Najera; Briana Johnson; Yenifer Morales; Steven Paul Woods
Journal:  Clin Neuropsychol       Date:  2021-07-10       Impact factor: 3.535

9.  Blast concussion and posttraumatic stress as predictors of postcombat neuropsychological functioning in OEF/OIF/OND veterans.

Authors:  Nathaniel W Nelson; Seth G Disner; Carolyn R Anderson; Bridget M Doane; Kathryn McGuire; Gregory J Lamberty; James Hoelzle; Scott R Sponheim
Journal:  Neuropsychology       Date:  2019-09-23       Impact factor: 3.295

10.  Performance validity in older adults: Observed versus predicted false positive rates in relation to number of tests administered.

Authors:  Jeremy J Davis
Journal:  J Clin Exp Neuropsychol       Date:  2018-05-20       Impact factor: 2.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.